Evidence map›Paper›PMID 37197629›Full record

ArticleTranslational lung cancer research2023

False positivity in break apart fluorescence in-situ hybridization due to polyploidy.

Anna Lena van Gulik, Ellen Sluydts, Liesbet Vervoort, Mark Kockx, Pim Kortman, Bauke Ylstra, Stephen P Finn, Lukas Bubendorf, Idris Bahce, Daoud Sie and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Translational lung cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Anna Lena van GulikInstitute of Pathology, University Hospital Cologne, Cologne, Germany.
Ellen SluydtsCellCarta, Antwerp, Belgium.
Liesbet VervoortCellCarta, Antwerp, Belgium.
Mark KockxCellCarta, Antwerp, Belgium.
Pim KortmanDepartment of Pathology, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.
Bauke YlstraDepartment of Pathology, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.
Stephen P FinnUniversity of Dublin, Trinity College and St. James's Hospital, Dublin, Ireland.
Lukas BubendorfInstitute of Pathology, University Hospital Basel, Basel, Switzerland.
Idris BahceDepartment of Pulmonology, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.
Daoud SieAmsterdam University Medical Center, Location VUmc, Tumor Genome Analysis Core, Amsterdam, The Netherlands.
Teodora RadonicDepartment of Pathology, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.
Birgit Lissenberg-WitteDepartment of Epidemiology and Data Science, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.
Erik ThunnissenDepartment of Pathology, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.
Amsterdam University Medical Centers · NLAmsterdam UMC Location VUmc · NLSt. James's Hospital · IEUniversity Hospital Cologne · DEUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In-situ hybridization (ISH) is a diagnostic tool in the detection of chromosomal anomalies, which has important implications for diagnosis, classification and prediction of cancer therapy in various diseases. Certain thresholds of number of cells showing an aberrant pattern are commonly used to declare a sample as positive for genomic rearrangements. The phenomenon of polyploidy can be misleading in the interpretation of break apart fluorescence in-situ hybridization (FISH). The aim of this study is to investigate the impact of cell size and ploidy on FISH results. Methods: In sections of varying thickness of control liver tissue and non-small cell lung cancer cases, nuclear size was measured and the number of Results: In liver cell nuclei the number of FISH/chromogenic ISH signals increases with nuclear size related to physiological polyploidy and is related to section thickness. In non-small cell lung cancer cases tumour cells with higher ploidy levels and nuclear size have an increased chance of single signals. Furthermore, additional lung cancer samples with borderline Conclusions: In case of polyploidy there is an increased likelihood of false positivity when using break apart FISH probes. Therefore, we state that prescribing one single cut-off in FISH is inappropriate. In polyploidy, the currently proposed cut-off should only be used with caution and the result should be confirmed by an additional technique.

Indexed as

false positivityfluorescence in-situ hybridization (FISH)in-situ hybridization (ISH)non-small cell lung cancer (NSCLC)Polyploidy

Identifiers

PMID37197629
PMCPMC10183404
OpenAlexW4366424383

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.